Leflunomide works by suppressing the overactive immune system, which helps to reduce joint swelling, stiffness, and pain. It is indicated for the treatment of active rheumatoid arthritis to improve physical function and slow joint damage. As the active ingredient in various reliable generic options, it is a foundation of long-term care. Our UK-based service ensures you have access to high-quality medications containing Leflunomide.
Leflunomide is a synthetic disease-modifying antirheumatic drug (DMARD). It is designed to slow the progression of inflammatory joint conditions rather than simply relieve pain. In the UK, leflunomide is most commonly encountered as the active ingredient in the tablet Arava.
The principal leflunomide-based product available in the United Kingdom is Arava tablets. Arava is supplied in several strengths, allowing physicians to tailor treatment to individual needs. Although Arava is the branded form, the same chemical substance is also marketed as generic leflunomide tablets once the original patent expires. Both the branded and generic versions are taken orally as tablets, and they are packaged in blister strips or bottle forms that protect them from moisture. Patients will usually find Arava listed on the pharmacy shelf alongside other DMARDs prescribed for chronic inflammatory disorders.
Leflunomide is primarily prescribed for adult rheumatoid arthritis (RA), a condition where the immune system mistakenly attacks joint tissue, leading to swelling, stiffness, and long-term damage. By moderating the immune response, leflunomide helps to reduce joint inflammation and slow structural deterioration.
Other inflammatory joint diseases for which leflunomide may be considered include:
These uses reflect the drug’s ability to temper an over-active immune system, making it a useful option for patients whose disease is not adequately controlled by first-line therapies. All indications are subject to approval by the Medicines and Healthcare products Regulatory Agency (MHRA) and the prescribing clinician’s judgment.
Leflunomide blocks a key step in the creation of pyrimidine nucleotides, which are essential building blocks for rapidly dividing cells, especially certain immune cells called lymphocytes. When these cells cannot multiply efficiently, the overall inflammatory activity in the joints diminishes. The effect is not immediate; most patients notice a gradual reduction in symptoms over several weeks, as the drug quietly reshapes the immune response.
These effects are generally short-lived and do not require a change in therapy unless they persist.
If any of these symptoms appear, seek emergency medical attention promptly.
For a complete list of interactions, refer to the specific product’s information leaflet.
Disease-modifying antirheumatic drug (DMARD): A class of medicines that slow the underlying disease process in arthritis rather than just relieving pain.
Immunosuppression: A reduction in the activity of the immune system, which can help control autoimmune conditions but may increase infection risk.
Pyrimidine: A type of molecule that cells need to make DNA and RNA; blocking its production limits the growth of certain immune cells.
This article offers general educational information about leflunomide as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing leflunomide may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
